Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Innovation Diagnostics Medical Device

Owlstone Medical Secures Funding To Develop Its Breath Biopsy Technology

  • Interviews

Executive Summary

The oversubscribed $58m funding round will enable the company to further work on its first-in-class breath biopsy technology, which aims to provide a cheap and convenient screening tool for several diseases.

You may also be interested in...



Angle Will Reshape Liquid Diagnostics By Capturing Circulating Tumor Cells

Following a successful fundraise, Angle is poised to further commercialize its proprietary cell-catching technology for cancer diagnosis

Boston Scientific TheraSphere Liver Cancer Treatment Succeeds In EPOCH Trial

Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.

Pixee Medical Concludes Knee+ Study Highlighting Its Efficacy

A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.

Table

View full table

Topics

Related Companies

Tags:
Innovation Diagnostics Medical Device
UsernamePublicRestriction

Register

MT144446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By